Evidence map›Paper›PMID 21987348›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Jennifer L Kelschenbach, Manisha Saini, Eran Hadas, Chao-Jiang Gu, Wei Chao, Galina Bentsman, Jessie P Hong, Tomas Hanke, Leroy R Sharer, Mary Jane Potash and 1 more

Abstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. EcoHIV Infection Disrupts Dopamine and Serotonin Transporter Function, Altering Release Dynamics in C57BL/6J Mice.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  4. Article
  5. Article
  6. EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Jennifer L KelschenbachMolecular Virology Division, St. Luke's-Roosevelt Hospital Center, 432 West 58th Street, New York, NY 10019, USA. jlk2152@columbia.edu
Manisha Saini
Eran Hadas
Chao-Jiang Gu
Wei Chao
Galina Bentsman
Jessie P Hong
Tomas Hanke
Leroy R Sharer
Mary Jane Potash
David J Volsky
St. Luke's-Roosevelt Hospital Center · USColumbia University · USUniversity of Oxford · GBRutgers, The State University of New Jersey · US

Funding

Toward a Mouse Model of HIV-1 Infection and Drug AddictionR01DA017618 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI POTASH, MARY JANE, VOLSKY, DAVID J · 2004 to 2015
$6.2M
Markers of HIV Brain Disease under HAART: Validation in a Mouse ModelR01MH083627 · NIMH · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI POTASH, MARY JANE, VOLSKY, DAVID J · 2008 to 2012
$2.6M
HIV sexual transmission in mice:study of microbicide efficacyR33AI079792 · NIAID · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI POTASH, MARY JANE · 2011 to 2013
$1.2M
NeuroAIDS Therapy in the EcoHIV Mouse ModelR21NS061646 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI VOLSKY, DAVID J · 2008 to 2009
$605k
HIV sexual transmission in mice:study of microbicide efficacyR21AI079792 · NIAID · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI POTASH, MARY JANE · 2008 to 2009
$431k
NIAID NIH HHS AI 079792NIAID NIH HHS R21 AI079792NIAID NIH HHS R33 AI079792NIDA NIH HHS DA 017618NIDA NIH HHS R01 DA017618NIMH NIH HHS MH 083627NIMH NIH HHS R01 MH083627NINDS NIH HHS NS 061646-01A1NINDS NIH HHS R21 NS061646
6 · The paper itself

Abstract

Infection by some viruses induces immunity to reinfection, providing a means to identify protective epitopes. To investigate resistance to reinfection in an animal model of HIV disease and its control, we employed infection of mice with chimeric HIV, EcoHIV. When immunocompetent mice were infected by intraperitoneal (IP) injection of EcoHIV, they resisted subsequent secondary infection by IP injection, consistent with a systemic antiviral immune response. To investigate the potential role of these responses in restricting neurotropic HIV infection, we established a protocol for efficient EcoHIV expression in the brain following intracranial (IC) inoculation of virus. When mice were inoculated by IP injection and secondarily by IC injection, they also controlled EcoHIV replication in the brain. To investigate their role in EcoHIV antiviral responses, CD8+ T lymphocytes were isolated from spleens of EcoHIV infected and uninfected mice and adoptively transferred to isogenic recipients. Recipients of EcoHIV primed CD8+ cells resisted subsequent EcoHIV infection compared to recipients of cells from uninfected donors. CD8+ spleen cells from EcoHIV-infected mice also mounted modest but significant interferon-γ responses to two HIV Gag peptide pools. These findings suggest EcoHIV-infected mice may serve as a useful system to investigate the induction of anti-HIV protective immunity for eventual translation to human beings.

Indexed as

AnimalsBrainChimeraChronic DiseaseDisease Models, AnimalFemaleHIVHIV InfectionsImmunohistochemistryMaleMiceMice, Inbred BALB CReal-Time Polymerase Chain ReactionSuperinfection

Identifiers

PMID21987348
PMCPMC3487595
OpenAlexW2001339252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.